CKAP4 and hepatocellular carcinoma: Moreover, patients exhibiting high expression of both CKAP4 and its palmitoyl acyltransferase DHHC2 demonstrated the best OS and DFS rates, despite the low expression of DHHC2 in HCC tissues.